BRAF and cancer: GDC-0980 was reported to be a potent inhibitor of breast, prostate and lung cancer cell growth and was much less effective against melanoma and pancreatic cancers, most likely due to the presence of highly active KRAS and BRAF usually encountered in these cancers.